Literature DB >> 23570615

Extracellular signal-regulated kinases (ERK) inhibitors from Aristolochia yunnanensis.

Zhong-Bin Cheng1, Wei-Wei Shao, Ye-Na Liu, Qiong Liao, Ting-Ting Lin, Xiao-Yan Shen, Sheng Yin.   

Abstract

Six new sesquiterpenoids, aristoyunnolins A-F (1-6), an artifact of isolation [7-O-ethyl madolin W (7)], and 12 known analogues were isolated from stems of Aristolochia yunnanensis. The structures were determined by combined chemical and spectral methods, and the absolute configurations of compounds 2, 3, 5-7, 9, 14, and 17 were determined by the modified Mosher's method and CD analysis. Compounds 1-19 were screened using a bioassay system designed to evaluate the effect on mitogen-activated protein kinases (MAPKs) signaling pathways. Among three MAPKs (ERK1/2, JNK, and p38), compounds 1, 4, 10-13, 16, 18, and 19 exhibited selective inhibition of the phosphorylation of ERK1/2. Compounds 16 and 19 were more active than the positive control PD98059, a known inhibitor of the ERK1/2 signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23570615     DOI: 10.1021/np300887d

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  3 in total

1.  A cytotoxic decahydronaphthalenylpropenal derivative and tetrahydrofuran lignans from the stems of Cameraria latifolia.

Authors:  Yulin Ren; Heebyung Chai; Michael Goetz; A Douglas Kinghorn
Journal:  Tetrahedron Lett       Date:  2013-09-04       Impact factor: 2.415

2.  Involucratusins A-H: Unusual Cadinane Dimers from Stahlianthus involucratus with Multidrug Resistance Reversal Activity.

Authors:  Qiang-Ming Li; Jian-Guang Luo; Rui-Zhi Wang; Xiao-Bing Wang; Ming-Hua Yang; Jun Luo; Ling-Yi Kong
Journal:  Sci Rep       Date:  2016-07-13       Impact factor: 4.379

3.  Aristolane-type Sesquiterpenoids from Nardostachys chinensis and Revised Structure of Aristolanhydride.

Authors:  Li-Xia Wang; Xian-Jun Jiang; Xiang-Mei Li; Mei-Fen Mao; Guo-Zhu Wei; Fei Wang
Journal:  Nat Prod Bioprospect       Date:  2019-03-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.